✦ LIBER ✦
P377 Safety profile and discontinuation rate of infliximab and adalimumab in patients with Crohn's disease and ulcerative colitis: experience from a tertiary care hospital in Qatar over a 7 year period
✍ Scribed by Sharma, M.; Al Kaabi, S.; Al Dweik, N.; John, A.; Wani, H.; Al Ejji, K.; Al Mohanadi, M.; Derbala, M.; Yacoub, R.; Pasic, F.; Butt, T.; ElBedawi, M.; Singh, R.
- Book ID
- 123555262
- Publisher
- Oxford University Press
- Year
- 2013
- Tongue
- English
- Weight
- 52 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1873-9946
No coin nor oath required. For personal study only.